Global Olaparib API Market Scope and Opportunities Analysis 2021 2031

Posted by Prasad on April 21st, 2021

Olaparib is used in treatment of advanced epithelial ovarian cancer, breast cancer and pancreatic cancer. Olaparib with bevacizumab during ovarian cancer chemotherapy. Olaparib API is a pharmaceutical ingredient used in the manufacturing of Olaparib drug for various disorders like breast cancer, pancreatic cancer, and ovarian cancer. According to the WHO, in 2018 there were around 627,000 women died from breast cancer. Rising prevalence of cancer is expected to rise the demand of Olaparib API in the global market.

For detailed insights on enhancing your product footprint, request for a sample here –

Moreover, Covid 19 pandemic cause Obstruction in production activities and logistics network disruption occurs due to lockdown implemented in various countries will have short term negative impact on Olaparib API market growth rate. Beside, treatment adoption and diagnosis rate is reduced owing to decline visits to hospitals and clinics is expected to delay the growth of Olaparib API market. Most of Key players focus on developing coronavirus treatment and diagnostic kits this will hinder Olaparib API market growth. Pharmaceutical and biopharmaceutical companies shift their focus to develop coronavirus diagnostic kits and treatment option this will hamper growth of Olaparib API market.

Olaparib API market: Segmentation

The global market for Olaparib API is segmented based on the Indication, End User

Based on Indication, Olaparib API market is segmented into following;

  • Ovarian cancer
  • Breast Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Others

Based on End User, global Olaparib API market is segmented into following:

  • Contract Manufacturing Organizations (CMOs)
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Pharmaceutical Companies

Olaparib API market: Overview

Global increase in Olaparib API market consolidation activities such as new setting of new manufacturing facilities or capacity expansion. Olaparib API manufacturing development, mergers & acquisitions, services agreements will aid in substantial market potential. Moreover Key manufacturers with intent to expand their services and distribution network can look for emerging nations as lucrative markets for investments. Olaparib API therapeutics currently represent the most promise and have experienced the most success within the overall class.

Olaparib API market: Key market players

Some of the key market players in Olaparib API market are ScinoPharm Taiwan, Ltd, Transo-Pharm USA LLC, ALP Pharm Beijing Co., Ltd, MSN Laboratories Pvt Ltd, Alembic Pharmaceuticals Limited, Exelixis Inc, Pfizer Inc, AstraZeneca plc, Novartis AG and Bayer AG.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website:

Like it? Share it!


About the Author

Joined: January 19th, 2021
Articles Posted: 51

More by this author